The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management

J Crohns Colitis. 2010 Feb;4(1):28-62. doi: 10.1016/j.crohns.2009.12.002. Epub 2010 Jan 15.
No abstract available

Publication types

  • Consensus Development Conference

MeSH terms

  • Adrenal Cortex Hormones / therapeutic use
  • Adult
  • Aminosalicylic Acids / therapeutic use
  • Anti-Bacterial Agents / therapeutic use
  • Anti-Inflammatory Agents / adverse effects
  • Anti-Inflammatory Agents / therapeutic use
  • Antibodies, Monoclonal / therapeutic use
  • Child
  • Constriction, Pathologic / surgery
  • Crohn Disease / pathology
  • Crohn Disease / therapy*
  • Diet Therapy
  • Humans
  • Immunosuppressive Agents / adverse effects
  • Immunosuppressive Agents / therapeutic use
  • Infliximab
  • Intestines / surgery
  • Methotrexate / therapeutic use
  • Purines / therapeutic use
  • Recurrence
  • Remission Induction
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors

Substances

  • Adrenal Cortex Hormones
  • Aminosalicylic Acids
  • Anti-Bacterial Agents
  • Anti-Inflammatory Agents
  • Antibodies, Monoclonal
  • Immunosuppressive Agents
  • Purines
  • Tumor Necrosis Factor-alpha
  • Infliximab
  • Methotrexate